Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant (CHARMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02108522
Recruitment Status : Active, not recruiting
First Posted : April 9, 2014
Last Update Posted : May 29, 2019
Sponsor:
Collaborators:
Center for Cell and Gene Therapy, Baylor College of Medicine
Texas Children's Hospital
The Methodist Hospital System
Information provided by (Responsible Party):
ViraCyte

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : January 2018
  Estimated Study Completion Date : June 2020
  Certification/Extension First Submitted : May 10, 2019